<unk>  is approved for the treatment of non-small-cell lung cancer. It is used off-label for other cancers such as metastatic breast cancer. It is also active in rhabdomyosarcoma.
Vinorelbine
Paclitaxel
Vincristine
Doxorubicin
Normustine
Bendamustine
Epirubicin
Trifluridine